The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection

Hepatology

Volumn 36, Issue 3, 2002, Pages 743-754

  Barnes, Eleanor ^a,b   Harcourt, Gillian ^b   Brown, Dave ^a   Lucas, Michaela ^b   Phillips, Rodney ^b   Dusheiko, Geoffrey ^a   Klenerman, Paul ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENOTYPE; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 0036727325     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.35344     Document Type: Article

References (40)

1. HCV: Epidemiology and transmission
2. Analysis of successful immune responses in persons infected with hepatitis C virus
3. Role of the specific T-cell response for clearance and control of hepatitis C virus
4. Effect of HLA class II genotype on T helper lymphocyte responses and viral control in HCV infection
5. CTL responses are induced during acute HCV infection but are not sustained
6. Recurrence of HCV after loss of virus specific CD4+ T cell response in acute hepatitis C
7. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
8. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells
9. Type I IFNs enhance the terminal differentiation of dendritic cells
10. Ribavirin treatment for patients with chronic hepatitis C: Results of a placebo-controlled study
11. Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile
12. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
13. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
14. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
15. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers
16. Management of hepatitis C
17. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
18. CTL response to HCV-derived peptides containing the HLA-A2.1 binding motif
19. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
20. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers
21. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions
22. Why do cytotoxic T lymphocytes fail to eliminate HCV? Lessons from studies using MHC class I tetramers
23. Determinants of viral clearance and persistence during acute hepatitis C virus infection
24. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with HCV
25. Quantitative analysis of HCV-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers
26. Association of hepatitis C virus-specific CD8+ T cells with viral
27. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
28. Late escape from an immunodominant CTL response associated with progression to AIDS
29. Immune control of HIV-1 after early treatment of acute infection
30. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
31. Impairment of CD4(+) T cell responses during chronic virus infection
32. Comprehensive analysis of CD8+ T-cell responses against HCV reveals multiple unpredicted specificities
33. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained
34. Viral immune evasion due to persistence of activated T cells without effector function
35. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals
36. Direct functional analysis of epitope-specific CD8+ T cells in peripheral blood
37. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients
38. Immunobiology of hepatitis C virus (HCV) infection: The role of CD4 T cells in HCV infection
39. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes
40. Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence